Top

Published in:

Open Access 01-02-2008 | Research article

Rheumatic Diseases in China

Authors: Qing Yu Zeng, Ren Chen, John Darmawan, Zheng Yu Xiao, Su Biao Chen, Richard Wigley, Shun Le Chen, Nai Zheng Zhang

Published in: Arthritis Research & Therapy | Issue 1/2008

Abstract

Introduction

Epidemiological studies of rheumatic diseases have been conducted during the past 20 years in China. The aim of this study was to clarify prevalence rates of common rheumatic diseases in China.

Methods

Relevant reports of population-based surveys conducted from 1980 to 2006 were retrieved. Studies using the World Health Organization-International League of Associations for Rheumatology COPCORD (Community Oriented Program for Control of Rheumatic Diseases) protocol and those that did not employ this protocol but were published in recognized journals were identified and analyzed.

Results

Thirty-eight surveys including 241,169 adults from 25 provinces/cities were pooled for analysis. The prevalence of rheumatic complaints ranged from 11.6% to 46.4%, varying by locality, study protocol and age of the people surveyed. Prevalence of symptomatic osteoarthritis (OA) varied from 5.1% to 20.8%, with common sites of involvement being the lumbar spine, knee joint and cervical spine. Compared with rates of radiographic and symptomatic knee OA in the USA, elderly men in Beijing exhibited similar prevalence rates and elderly women exhibited a higher prevalence. The prevalence of hip OA and hand OA was much lower in Chinese than in Caucasian populations, but both kinds of OA were more common in coal miners. The prevalence of ankylosing spondylitis ranged from 0.2% to 0.54% among Han ethnic Chinese and were lower among mixed ethnic populations. The prevalence of psoriatic arthritis ranged from 0.01% to 0.1%, and that of reactive arthritis was 0.02%; undifferentiated spondyloarthropathy was identified in 0.64% to 1.2% of the individuals included in the surveys. The prevalence of rheumatoid arthritis (RA) ranged from 0.2% to 0.93%, with the highest rate being reported from a Taiwan urban area. In mainland China there were no significant differences in prevalence of RA between the northern and southern parts of China, or between different ethnic groups. The prevalence of hyperuricemia increased after the 1980s. The prevalence of gout was found to have increased in recent decades from 0.15% to 1.98%, apart from in the Taiwan aborigines, among whom the highest prevalence rate of 11.7% was recorded. The prevalence of primary Sjögren's syndrome in Beijing was 0.77% by the Copenhagen criteria and 0.33% by the San Diego criteria. The prevalence of soft tissue rheumatism was 2.5% to 5.7%. Fibromyalgia was seldom observed in China.

Conclusion

Rheumatic diseases are common in China. The prevalence of rheumatic complaints varied with the locality surveyed. The prevalence of OA is comparable with that in Western countries but varies in terms of joint involvement. The prevalence of ankylosing spondylitis is similar to that in Caucasians. Except in Taiwan, the prevalence of RA in China is lower than that in developed countries. The prevalence of hyperuricemia and gout increased after the 1980s, but it remains lower than that in developed countries. More studies are required to evaluate prevalence rates among minority groups in the west and northwest parts of China, and further study is needed to address fibromyalgia in China.

Available only for authorised users

Muirden KD: Rheumatic diseases in China. J Rheumatol. 1994, 21: 1383-1384.PubMed

Zhang NZ: A Resume of epidemiological surveys of several main rheumatic diseases in China. Chin Med J. 1998, 111: 195-196.PubMed

Chen SL, Zeng QY: The COPCORD study in China [abstract]. Programme and Abstracts of the 8th Asia Pacific League of Associations for Rheumatology Congress of Rheumatology. Melbourne, Australia, s182-21–26 April 1996

Beasley RP, Bennett PH, Lin CC: Low prevalence of rheumatoid arthritis in Chinese. Prevalence survey in a rural community. J Rheumatol. 1983, 11-15. Suppl 10

Fang Q, Chen HZ, Yu ZF, Huang BJ, Yu CH: Survey of uric acid among healthy Chinese and its relation to blood lipid. Chin J Intern Med (Chinese). 1983, 22: 434-438.

Sun G, Xia D, Fang H: A survey of incidence of rheumatoid arthritis (RA) and ankylosing spondylitis (AS). Chin J Rehabil Med (Chinese). 1988, 3: 115-117.

Huang M, Chen S, Lu G, Wang W, Jiang S, Zhang L, Jin W, Yu J, Xu S, Cai Y, et al: Epidemiological survey on systemic lupus erythematosus. Chin J Intern Med (Chinese). 1985, 24: 451-453.

Zeng QY, Huang S, Zhou X, Li D, Chen W, Xiao Z, Li X, Xu J: Population and family survey of ankylosing spondylitis with HLA-B27 determinations. Chin J Intern Med (Chinese). 1987, 26: 387-389.

Wigley RD, Zhang NZ, Zeng QY, Shi CS, Hu DW, Couchman K, Duff IF, Bennett PH: Rheumatic diseases in China: ILAR-China study comparing the prevalence of rheumatic symptoms in northern and southern rural populations. J Rheumatol. 1994, 21: 1484-1490.PubMed

10.

Yang L, Guo J, Lin H: Investigation on osteoarthropathy in 1000 coal miners. Chin J Trad Med Traum Ort (Chinese). 1989, 5: 10-13.

11.

Li Y, Stamler J, Xiao Z, Folsom A, Tao S, Zhang H: Serum uric acid and its correlate in Chinese adult population, urban and rural, of Beijing. The PRC-USA Collaborative Study in Cardiovascular and Cardiopulmonary Epidemiology. Int J Epidemiol. 1997, 26: 288-296. 10.1093/ije/26.2.288.CrossRefPubMed

12.

Zhang F, Zhao Y, Ren X: Report on survey of rheumatic diseases in northern very cold area of China. Rheum Dis Integrat Chin Trad Med Moden Med (Chinese). 1992, 1: 1-4.

13.

Xu D, Li B, Chen H, Ruan Z, Zeng Y, Yang X: Epidemiological study of systemic lupus erythematosus in Guangzhou area. Chin J Dermatol (Chinese). 1992, 25: 50-52.

14.

Qian L, Chen J, He L, Liu R, Dong G: An epidemiological survey and analysis on the rheumatic diseases among peasants in Ningxia frigid high elevation region. Environ Sci (Chinese). 2001, 107-109. Suppl 22

15.

Xu JC, Chen R, Xu LD, Li XJ, Huang SB, Xiao ZY, Xie SH, Zhou XG, Zeng QY: An investigation of the causal factors of the higher prevalence rate of joint complain in the north than south. J Shantou Univ Med Coll (Chinese). 1993, 2: 50-52.

16.

Chen R, Xu LD, Xu JC, Li XJ, Zhou XG, Xiao ZY, Huang SB, Xie SH: Population study of symptomatic osteoarthritis. J Shantou Univ Med Coll (Chinese). 1993, 2: 54-56.

17.

Zeng QY, Zhou XG, Xiao ZY, Huang SB, Xie SH, Xu LD, Chen R, Xu JC, Li XJ: BMD of distal radius and gout in the population of middle schools in Chenghai downtown. J Shantou Univ Med Coll (Chinese). 1993, 6: 46-49.

18.

Lau E, Symmons D, Bankhead C, Macgregor A, Donnan S, Silman A: Low prevalence of rheumatoid arthritis in the urbanized Chinese of Hong Kong. J Rheumatol. 1993, 20: 1133-1137.PubMed

19.

Chou CT, Pei L, Chang DM, Lee CF, Schumacher HR, Liang MH: Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol. 1994, 21: 302-306.PubMed

20.

Zhang N, Shi Q, Zhang X, Sha L, Wang Y, Zhao S, Lu S, Yu G, Qu H: An epidemiological study of knee osteoarthritis. Chin J Intern Med (Chinese). 1995, 34: 84-87.

21.

Zhang NZ, Shi CS, Yao QP, Pan GX, Wang LL, Wen ZX, Li XC, Dong Y: Prevalence of primary Sjögren's syndrome in China. J Rheumatol. 1995, 22: 659-661.PubMed

22.

Chou CT, Lai JS: The epidemiology of hyperuricemia and gout in Taiwan aborigines. Br J Rheumatol. 1998, 37: 258-262. 10.1093/rheumatology/37.3.258.CrossRefPubMed

23.

Zeng QY, Chen R, Xiao ZY, Liu Y, Xu J, Wigkey RD: Shantou COPCORD study: stage I. APLAR Bull. 1995, 13: 74-76.

24.

Chang H, Pan W, Yeh W, Tsai K: Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993–1996). J Rheumatol. 2001, 28: 1640-1646.PubMed

25.

Zhang H, Liu Z, Su H, Zhou H, Xun Y, Jiang X: Epidemiological studies on rheumatoid arthritis and ankylosing spondylitis in rural area of Shandong province. Chin J Rheumatol (Chinese). 1998, 2: 85-87.

26.

Chen S, Du H, Wang Y, Xu L: The epidemiology study of hyperuricemia and gout in a community population of Huangpu District in Shanghai. Chin Med J. 1998, 111: 228-230.PubMed

27.

Jiang B, Zhang Y, Xu X, Mei H, Wang G, Ding F, Ding Z: A prevalence study of rheumatic diseases in eastern coastline of Shandong province. Acta Acad Med Shandong (Chinese). 2001, 39: 210-211.

28.

Dai S, Han X, Zhao D, Shi Y, Liu Y, Meng J: Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China: a COPCORD study. J Rheumatol. 2003, 30: 2245-2251.PubMed

29.

Zeng QY, Wang Q, Chen R, Xiao Z, Huang S, Xu J: Primary gout in Shantou: a clinical and epidemiological study. Chin Med J. 2003, 116: 66-69.PubMed

30.

Chen R, Wang Q, Lin Q, Wu X, Xu J, Xie S, Zeng QY: Epidemiological study of seronegative spondyloarthropathies. Chin J Rheumatol (Chinese). 2000, 4: 240-241.

31.

Chen R, Du L, Lin Q, Chen S, Lin L, Xu J, Xie S: Epidemiological study of seronegative spondyloarthropathies in Beijing area. Chin J Prim Med Pharm (Chinese). 2002, 9: 593-594.

32.

Nevitt MC, Xu L, Zhang Y, Lui L, Yu W, Lane NE, Qin M, Hochberg MC, Cummings SR, Felson DT: Very low prevalence of hip osteoarthritis among Chinese elderly in Beijing, China, compared with Whites in the United States. Arthritis Rheum. 2002, 46: 1773-1779. 10.1002/art.10332.CrossRefPubMed

33.

Zhang Y, Xu L, Nevitt MC, Niu J, Goggins JP, Aliabadi P, Yu W, Lui LY, Felson DT: Lower prevalence of hand osteoarthritis among Chinese subjects in Beijing compared with white subjects in the United States: the Beijing Osteoarthritis Study. Arthritis Rheum. 2003, 48: 1034-1040. 10.1002/art.10928.CrossRefPubMed

34.

Zhang Y, Xu L, Nevitt MC, Aliabadi P, Yu W, Qin M, Lui LY, Felson DT: Comparison of the prevalence of knee osteoarthritis between the elderly Chinese population in Beijing and whites in the United States: the Beijing Osteoarthritis Study. Arthritis Rheum. 2001, 44: 2065-2071. 10.1002/1529-0131(200109)44:9<2065::AID-ART356>3.0.CO;2-Z.CrossRefPubMed

35.

Cao T, Huang H, Duan Y, Ji Y, Chen L, Dong D, Li H, Wang B, Zhang G: Epidemiological study of ankylosing spondylitis of the men of military officers and soldiers in Northeast Military Region. Chin J Rheumatol (Chinese). 2000, 4: 307-308.

36.

Nan H, Qiao Q, Dong Y, Gao W, Tang B, Qian R, Tuomilehto J: The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China. J Rheumatol. 2006, 33: 1346-1350.PubMed

37.

Shao J, Mo B, Yu R, Li Z, Liu H, Xu Y: Epidemiological study on hyperuricemia and gout in community of Nanjing. Chin J Dis Control Prev (Chinese). 2003, 7: 305-308.

38.

Du H, Chen S, Bao C, Wang X, Lu Y, Gu Y, Xu J, Chai W, Chen J, Nakamura H, et al: Prevalence and risk factors of knee osteoarthritis in Huang-Pu District, Shanghai, China. Rheumatol Int. 2005, 25: 585-590. 10.1007/s00296-004-0492-7.CrossRefPubMed

39.

Zang C, Zeng QY, Li X, Dong H, Zhang A: Epidemiological study of osteoarthritis in Taiyuan. Shanxi Med J (Chinese). 2006, 35: 767-770.

40.

Dong H, Zang C, Zhang A, Zheng J: Epidemiological study of seronegative spondyloarthropathies in Taiyuan. Chin Remedies Clinics (Chinese). 2006, 6: 262-265.

41.

Zang CH, Zeng QY, Li X, Dong H, Zhang A: Epidemiological study of rheumatic diseases in Taiyuan area. Chin Remd Clin (Chinese). 2007, 7: 597-602.

42.

Zeng QY, Darmawan J, Xiao ZY, Chen SB, Chen R, Lin K, Wigley R, Chen SL, Zhang NZ: Risk factors associated with rheumatic complaints: a WHO-ILAR COPCORD study in Shantou, southeast China. J Rheumatol. 2005, 32: 920-927.PubMed

43.

Zhang G, Yang Y, Feng Z, Zhang Y, Feng M, Ji Y, Lu Q, Ma J, Ji Y, Mao X, et al: Report of HLA distribution of Chinese Bone Marrow Bank (Shanghai). Chin J Organ Transplant (Chinese). 2001, 22: 179-185.

44.

Song Y, Zhu C, Lv H, Rong Z, Nie X, Wang M, Liu Y: HLA-A, B, DRB1 gene distribution of Shandong Han ethnic population bone marrow bank. Chin J Blood Transfus (Chinese). 2005, 18: 327-329.

45.

Deng Y, Yang G, Wu D, Hu S, Li S, Zhu J, Zhu B, Liu Y: HLA-A, B, DRB1 gene polymorphism of Beijing population was studied by high-resolution polymerase chain reaction sequence-based typing. Chin J Med Genet (Chinese). 2006, 23: 103-106.

46.

Wu G, Deng Z, Gao S, Cheng L, Jin S, Zhou D, Li Z, Zhou H, Zhang X, Wei T, et al: Study of HLA polymorphism in the 6965 Han bone marrow registry donors. Chin J Hematol (Chinese). 2004, 25: 473-477.

47.

Dai Q, Huang Y: Significance of HLA-B27 determination in the diagnosis of ankylosing spondylitis. Occupation Health (Chinese). 2006, 22: 2005-2006.

48.

Liu H: HLA-B27 in ankylosing spondylitis patients in Yuxi area. Shandong Med J (Chinese). 2006, 46: 69-70.

49.

Lin J, Lv H, Chen Z, Jiang D, Wang S, Feng C: Ankylosing spondylitis and HLA-B27 subtypes: a disease related research in Chinese Han nationality. J Beijing Med Univ (Chinese). 1994, 26: 323-326.

50.

Lin J, Lv H, Feng C: Ankylosing spondylitis and heterogenity of HLA-B27 in Chinese. Chin J Surg (Chinese). 1996, 34: 333-335.

51.

Jiang L, Fan L, Yang J, Yao F, Zhou J, Xu R, Gao P: Study on ankylosing spondylitis and HLA-B27 alleles. Chin J Immunol (Chinese). 1997, 13: 345-348.

52.

Yang G, Deng Y, Yan C, Wu D, Hu S, Zhu B, Li S, Zhang X, Liu Y: Frequencies distribution of human leukocyte antigen-B27 subtypes in healthy Chinese. Acta Acad Med Sin (Chinese). 2006, 28: 240-243.

53.

Huang F, Zhao H, Shi G: Family surveys of 5 cases of spondyloarthropathies. Chin J Intern Med (Chinese). 1994, 33: 44-45.

54.

Cai Q, Han X, Chen R, Yang B, Zhao F: Family aggregation of ankylosing spondylitis. Chin J Rheumatol (Chinese). 2003, 7: 668-672.

55.

Yang X, Tang F, Yin P: The trend of proportion among inpatients with gout in 21 hospitals during the past 15 years. Chin J Epidemiol (Chinese). 1996, 17: 10-12.

56.

Minaur N, Sawyers S, Parker J, Darmawan J: Rheumatic disease in an Australian Aboriginal community in North Queensland, Australia. A WHO-ILAR COPCORD survey. J Rheumatol. 2004, 31: 965-972.PubMed

57.

Haq SA, Darmawan J, Islam MN, Uddin MZ, Das BB, Rahman F, Chowdhury MAJ, Alam MN, Mahmud TAK, Chowdhury MR, et al: Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study. J Rheumatol. 2005, 32: 348-353.PubMed

58.

Chopra A, Saluja M, Patil J, Tandale HS: Pain and disability, perceptions and beliefs of a rural Indian population: a WHO-ILAR COPCORD study. J Rheumatol. 2002, 29: 614-621.PubMed

59.

Darmawan J, Valkenburg HA, Muirden KD, Wigley RD: Epidemiology of rheumatic diseases in rural and urban populations in Indonesia. Ann Rheum Dis. 1992, 51: 525-528.PubMedCentralCrossRefPubMed

60.

Dans LF, Tankeh-Torres S, Amante CM, Penserga EG: The prevalence of rheumatic diseases in a Filipino urban population: a WHO-ILAR COPCORD study. J Rheumatol. 1997, 24: 1814-1819.PubMed

61.

Chaiamnuay P, Darmawan J, Muirden KD, Assawatanabodee P: Epidemiology of Rheumatic disease in rural Thailand: a WHO-ILAR COPCORD study. J Rheumatol. 1998, 25: 1382-1387.PubMed

62.

Minh Hoa TT, Darmawan J, Chen SL, Van Hung N, Thi Nhi C, Ngoc An T: Prevalence of the rheumatic diseases in urban Vietnam: a WHO-ILAR COPCORD study. J Rheumatol. 2003, 30: 2252-2256.PubMed

63.

Veerapen K: Epidemiology of rheumatic disease in Malaysia. APLAR Rheumatology. Edited by Nasution R. London, UK: Churchill Livingstone. 1992, 397-399.

64.

Chopra A, Patil J, Billempelly V, Relwani J, Tandle HS: Prevalence of rheumatic diseases in a rural population in western India: a WHO-ILAR COPCORD study. J Assoc Physicians India. 2001, 49: 240-246.PubMed

65.

Wigley R, Manahan L, Muirden KD, Caragay R, Pinfold B, Couchman KG, Valkenburg HA: Rheumatic disease in a Philippine village. II: a WHO-ILAR- APLAR COPCORD study, phases II and III. Rheumatol Int. 1991, 11: 157-161. 10.1007/BF00332554.CrossRefPubMed

66.

Lawrence JS: Occupational aspects of the rheumatic diseases. Rheumatism in Populations. Edited by: Lawrence JS. 1977, London, UK: William Heinemann Medical Books Ltd, 466-493.

67.

Felson DT, Zhang Y: An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 1998, 41: 1343-1355. 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9.CrossRefPubMed

68.

Zeng QY, Huang S, Xiao Z, Chen S, Liu X, Zhou X: Osteoarthritis: clinical and epidemiological investigation. Chin J Intern Med (Chinese). 1995, 34: 88-90.

69.

Carter ET, McKenna CH, Brian DD, Kurland LT: Epidemiology of ankylosing spondylitis in Rochester, Minnesota: 1935–1973. Arthritis Rheum. 1979, 22: 365-370. 10.1002/art.1780220408.CrossRefPubMed

70.

Gran JT, Husby G, Hordvik M: Prevalence of ankylosing spondylitis in males and females in a young middle aged population of Tromso, Northern Norway. Ann Rheum Dis. 1985, 44: 359-367.PubMedCentralCrossRefPubMed

71.

Darmawan J, Muirden KD, Valkenburg HA, Wigley RD: The epidemiology of rheumatoid arthritis in Indonesia. Br J Rheumatol. 1993, 32: 537-540. 10.1093/rheumatology/32.7.537.CrossRefPubMed

72.

Senna ER, De Barros ALP, Silva EO, Costa IF, Pereira LVB, Ciconelli RM, Ferraz MB: Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol. 2004, 31: 594-597.PubMed

73.

Cardiel MH, Rojas-Serrano J: Community based study to estimate prevalence, burden of illness and help seeking behavior in rheumatic diseases in Mexico City. a COPCORD study. Clin Exp Rheumatol. 2002, 20: 617-624.PubMed

74.

Silman A, Hochberg MC, (editors): Epidemiology of the Rheumatic Diseases. 1993, Oxford, UK: Oxford University Press, 16-20.

75.

Darmawan J, Valkenburg HA, Muirden KD, Wigley RD: The epidemiology of gout and hyperuricemia in a rural population of Java. J Rheumatol. 1992, 19: 1595-1599.PubMed

76.

Darmawan J, Lutalo SK: Gout and hyperuricaemia. Baillieres Clin Rheumatol. 1995, 9: 83-94. 10.1016/S0950-3579(05)80146-3.CrossRefPubMed

77.

Harris CM, Lloyd DCEF, Lewis J: The prevalence and prophylaxis of gout in England. J Clin Epidemiol. 1995, 48: 1153-1158. 10.1016/0895-4356(94)00244-K.CrossRefPubMed

78.

Lawrence RC, Hochberg MC, Kelsey JL, Mcduffie FC, Medsger TA, Felts WR, Shulman LE: Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol. 1989, 16: 427-441.PubMed

79.

Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995, 38: 19-28. 10.1002/art.1780380104.CrossRefPubMed

80.

Buskila D, Sarzi-Puttini P: Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome. Arthritis Res Ther. 2006, 8: 218-10.1186/ar2005.PubMedCentralCrossRefPubMed

81.

Xu KF: Systemic lupus erythematosus in Chinese populations. APLAR Bull. 1995, 13: 70-74.

82.

Petri M: Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2002, 16: 847-858. 10.1053/berh.2002.0259.CrossRefPubMed

Title: Rheumatic Diseases in China
Authors: Qing Yu Zeng
Ren Chen
John Darmawan
Zheng Yu Xiao
Su Biao Chen
Richard Wigley
Shun Le Chen
Nai Zheng Zhang
Publication date: 01-02-2008
Publisher: BioMed Central
Published in: Arthritis Research & Therapy / Issue 1/2008
Electronic ISSN: 1478-6362
DOI: https://doi.org/10.1186/ar2368

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2008

Biomarkers in osteoarthritis

Biomarker profiles in serum and saliva of experimental Sjögren's syndrome: associations with specific autoimmune manifestations

Faecal blood loss with aspirin, nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors: systematic review of randomized trials using autologous chromium-labelled erythrocytes

Complement and arthritis: another step in understanding

Association of reduced heme oxygenase-1 with excessive Toll-like receptor 4 expression in peripheral blood mononuclear cells in Behçet's disease

What is the clinical and ethical importance of incidental abnormalities found by knee MRI?

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials